Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-24T04:37:08.391Z Has data issue: false hasContentIssue false
  • English
  • Français

Increased rates of secondary bacterial infections, including Enterococcus bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19)

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  06 September 2021

Catherine DeVoe Open the ORCID record for Catherine DeVoe [Opens in a new window] ,
Mark R. Segal ,
Lusha Wang ,
Kim Stanley ,
Sharline Madera ,
Joe Fan ,
Jonathan Schouest ,
Renee Graham-Ojo ,
Amy Nichols  and
Priya A. Prasad
...Show all authors
Catherine DeVoe
Affiliation:
Division of Infectious Diseases, University of California, San Francisco, California
Mark R. Segal
Affiliation:
Department of Epidemiology and Biostatistics, University of California, San Francisco, California
Lusha Wang
Affiliation:
Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California
Kim Stanley
Affiliation:
Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California
Sharline Madera
Affiliation:
Division of Infectious Diseases, University of California, San Francisco, California
Joe Fan
Affiliation:
Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California
Jonathan Schouest
Affiliation:
Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California
Renee Graham-Ojo
Affiliation:
Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California
Amy Nichols
Affiliation:
Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California
Priya A. Prasad
Affiliation:
Division of Hospital Medicine, University of California, San Francisco, California
Rajani Ghale
Affiliation:
Department of Pulmonary and Critical Care Medicine, University of California, San Francisco, California
Christina Love
Affiliation:
Division of Infectious Diseases, University of California, San Francisco, California
Yumiko Abe-Jones
Affiliation:
Division of Hospital Medicine, University of California, San Francisco, California
Kirsten N. Kangelaris
Affiliation:
Division of Hospital Medicine, University of California, San Francisco, California
Sarah L. Patterson
Affiliation:
Division of Rheumatology, University of California, San Francisco, California
Deborah S. Yokoe
Affiliation:
Division of Infectious Diseases, University of California, San Francisco, California Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California
Charles R. Langelier*
Affiliation:
Division of Infectious Diseases, University of California, San Francisco, California Department of Hospital Epidemiology and Infection Prevention, University of California, San Francisco, California Chan Zuckerberg Biohub, San Francisco, California
*
Author for correspondence: Charles Langelier, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We compared the rates of hospital-onset secondary bacterial infections in patients with coronavirus disease 2019 (COVID-19) with rates in patients with influenza and controls, and we investigated reports of increased incidence of Enterococcus infections in patients with COVID-19.

Design:

Retrospective cohort study.

Setting:

An academic quaternary-care hospital in San Francisco, California.

Patients:

Patients admitted between October 1, 2019, and October 1, 2020, with a positive SARS-CoV-2 PCR (N = 314) or influenza PCR (N = 82) within 2 weeks of admission were compared with inpatients without positive SARS-CoV-2 or influenza tests during the study period (N = 14,332).

Methods:

National Healthcare Safety Network definitions were used to identify infection-related ventilator-associated complications (IVACs), probable ventilator-associated pneumonia (PVAP), bloodstream infections (BSIs), and catheter-associated urinary tract infections (CAUTIs). A multiple logistic regression model was used to control for likely confounders.

Results:

COVID-19 patients had significantly higher rates of IVAC and PVAP compared to controls, with adjusted odds ratios of 4.7 (95% confidence interval [CI], 1.7–13.9) and 10.4 (95 % CI, 2.1–52.1), respectively. COVID-19 patients had higher incidence of BSI due to Enterococcus but not BSI generally, and whole-genome sequencing of Enterococcus isolates demonstrated that nosocomial transmission did not explain the increased rate. Subanalyses of patients admitted to the intensive care unit and patients who required mechanical ventilation revealed similar findings.

Conclusions:

COVID-19 is associated with an increased risk of IVAC, PVAP, and Enterococcus BSI compared with hospitalized controls, which is not fully explained by factors such as immunosuppressive treatments and duration of mechanical ventilation. The mechanism underlying increased rates of Enterococcus BSI in COVID-19 patients requires further investigation.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 10 , October 2022 , pp. 1416 - 1423
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Shah, NS, Greenberg, JA, McNulty, MC, et al. Bacterial and viral co-infections complicating severe influenza: incidence and impact among 507 US patients, 2013–14. J Clin Virol 2016;80:12–19.CrossRefGoogle Scholar
Youngs, J, Wyncoll, D, Hopkins, P, Arnold, A, Ball, J, Bicanic, T. Improving antibiotic stewardship in COVID-19: bacterial coinfection is less common than with influenza. J Infect 2020;81(3):e55–e57.CrossRefGoogle ScholarPubMed
Soriano, MC, Vaquero, C, Ortiz-Fernández, A, Caballero, A, Blandino-Ortiz, A, de Pablo, R. Low incidence of coinfection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. J Infect 2020. doi: 10.1016/j.jinf.2020.09.010.Google ScholarPubMed
Garcia-Vidal, C, Sanjuan, G, Moreno-García, E, et al. Incidence of coinfections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect 2020. doi: 10.1016/j.cmi.2020.07.041.Google ScholarPubMed
Hughes, S, Troise, O, Donaldson, H, Mughal, N, Moore, LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 2020;26:1395–1399.Google Scholar
Langford, BJ, So, M, Raybardhan, S, et al. Bacterial coinfection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020. doi: 10.1016/j.cmi.2020.07.016.CrossRefGoogle ScholarPubMed
Vaughn, VM, Gandhi, T, Petty, LA, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with COVID-19: a multihospital cohort study. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa1239.Google Scholar
Cai, Q, Huang, D, Ou, P, et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy 2020;75:1742–1752.CrossRefGoogle Scholar
Schmidt, M, Hajage, D, Lebreton, G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med 2020;8:1121–1131.CrossRefGoogle ScholarPubMed
Gamberini, L, Tonetti, T, Spadaro, S, et al. Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs. J Intensive Care 2020;8:80.CrossRefGoogle ScholarPubMed
Bonazzetti, C, Morena, V, Giacomelli, A, et al. Unexpectedly high frequency of enterococcal bloodstream infections in coronavirus disease 2019 patients admitted to an Italian ICU: an observational study. Crit Care Med 2021;49(1):e31–e40.CrossRefGoogle Scholar
Kokkoris, S, Papachatzakis, I, Gavrielatou, E, et al. ICU-acquired bloodstream infections in critically ill patients with COVID-19. J Hosp Infect 2021;107:95–97.CrossRefGoogle ScholarPubMed
Sepulveda, J, Westblade, LF, Whittier, S, et al. Bacteremia and blood culture utilization during COVID-19 surge in New York City. J Clin Microbiol 2020;58(8). doi: 10.1128/JCM.00875-20.CrossRefGoogle ScholarPubMed
Engsbro, AL, Israelsen, SB, Pedersen, M, et al. Predominance of hospital-acquired bloodstream infection in patients with COVID-19 pneumonia. Infect Dis (London) 2020;52:919–922.Google ScholarPubMed
Giacobbe, DR, Battaglini, D, Ball, L, et al. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest 2020;50(10):e13319.CrossRefGoogle ScholarPubMed
Cataldo, MA, Tetaj, N, Selleri, M, et al. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: an alarming “collateral effect.” J Glob Antimicrob Resist 2020;23:290–291.Google ScholarPubMed
Kampmeier, S, Tönnies, H, Correa-Martinez, CL, Mellmann, A, Schwierzeck, V. A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit. Antimicrob Resist Infect Control 2020;9:154.CrossRefGoogle Scholar
Jones, AE, Trzeciak, S, Kline, JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009;37:1649–1654.CrossRefGoogle ScholarPubMed
NHSN VAE. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/10-vae_final.pdf. Published 2021. Accessed August 30, 2021.Google Scholar
NHSN bloodstream infection event. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Published 2021. Accessed August 30, 2021.Google Scholar
Crawford, E, Kamm, J, Miller, S, et al. Investigating transfusion-related sepsis using culture-independent metagenomic sequencing. Clin Infect Dis 2020;71:1179–1185.CrossRefGoogle ScholarPubMed
Kamm, Jack. SNP pipeline for infectious disease. Github website. https://github.com/czbiohub/Spid.jl. Published 2021. Accessed August 30, 2021.Google Scholar
Li, H, Handsaker, B, Wysoker, A, Fennell, T, Ruan, J, Homer, N. The sequence alignment/map format and SAMtools. Bioinforma (Oxford) 2009;25. doi: 10.1093/bioinformatics/btp352.CrossRefGoogle ScholarPubMed
Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinforma (Oxford) 2014;30:1312–1313.Google ScholarPubMed
Huerta-Cepas, J, Serra, F, Bork, P. ETE 3: reconstruction, analysis, and visualization of phylogenomic data. Mol Biol Evol 2016;33:1635–1638.Google ScholarPubMed
COVID-19 therapeutic trial synopsis. World Health Organization website. https://www.who.int/publications-detail-redirect/covid-19-therapeutic-trial-synopsis. Accessed August 8, 2021.Google Scholar
Maes, M, Higginson, E, Pereira-Dias, J, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care 2021;25. doi: 10.1186/s13054-021-03460-5.Google ScholarPubMed
Razazi, K, Arrestier, R, Haudebourg, AF, et al. Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to coronavirus 19 disease. Crit Care (London) 2020;24:699.CrossRefGoogle ScholarPubMed
Rouzé, A, Martin-Loeches, I, Povoa, P, et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med 2021. doi: 10.1007/s00134-020-06323-9.CrossRefGoogle ScholarPubMed
Shahangian, A, Chow, EK, Tian, X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009;119:1910–1920.CrossRefGoogle ScholarPubMed
Sarma, A, Christenson, S, Mick, E, et al. COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone. Res Sq 2021. doi: 10.21203/rs.3.rs-141578/v1.Google ScholarPubMed
Feng, Y, Ling, Y, Bai, T, et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med 2020;201:1380–1388.Google ScholarPubMed
Blonz, G, Kouatchet, A, Chudeau, N, et al. Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region. Crit Care 2021;25. doi: 10.1186/s13054-021-03493-w.Google Scholar
Moretti, M, Van Laethem, J, Minini, A, Pierard, D, Malbrain, MLNG. Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study. J Infect Chemother. 2021. doi: 10.1016/j.jiac.2021.01.011.Google ScholarPubMed
Fakih, MG, Bufalino, A, Sturm, L, et al. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol 2021. doi: 10.1017/ice.2021.70.Google ScholarPubMed
Lamers, MM, Beumer, J, van der Vaart, J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science 2020;369:50–54.CrossRefGoogle ScholarPubMed
Klompas, M. Does this patient have ventilator-associated pneumonia? JAMA 2007;297:1583–1593.Google ScholarPubMed
Klompas, M. Interobserver variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010;38:237–239.Google ScholarPubMed
Klompas, M, Kulldorff, M, Platt, R. Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis 2008;46:1443–1446.CrossRefGoogle ScholarPubMed
Supplementary material: File

DeVoe et al. supplementary material

DeVoe et al. supplementary material

Download DeVoe et al. supplementary material(File)
File 8.5 MB